Howe Jolanda 4
4 · Mirum Pharmaceuticals, Inc. · Filed Jul 3, 2025
Insider Transaction Report
Form 4
Howe Jolanda
SVP, GLOBAL CONTROLLER
Transactions
- Sale
Common Stock
2025-07-03$49.08/sh−477$23,411→ 2,426 total - Exercise/Conversion
Common Stock
2025-07-01+1,041→ 3,467 total - Sale
Common Stock
2025-07-02$48.25/sh−564$27,213→ 2,903 total - Exercise/Conversion
Restricted Stock Units
2025-07-01−1,041→ 0 total→ Common Stock (1,041 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
- [F2]Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
- [F3]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 16, 2024.
- [F4]The restricted stock units vest in a series of three successive equal annual installments beginning July 1, 2023.